Top Industry Leaders in the Synthetic Biology Market
Funding Frenzy and Acquisitions: Twist Bioscience Raises $200 Million in Series H Round: In October 2023, this DNA synthesis leader secured significant funding to expand its manufacturing capacity and advance its synthetic biology technologies.
Ginkgo Bioworks Acquires Synlogic Therapeutics: This November 2023 acquisition strengthens Ginkgo's cell engineering capabilities and expands its pipeline of potential therapeutic solutions.
CRISPR-based Malaria Vaccine Candidate Progress: SynBio company Synpromics and the Wellcome Sanger Institute unveiled promising results for their synthetic biology-based vaccine candidate against malaria.
Bioprinting Tissues for Transplantation: Researchers at MIT successfully bioprinted a miniature, functional human heart ventricle using synthetic biology techniques, raising hopes for future organ transplantation solutions.
List of Synthetic Biology Key companies in the market- Bota Biosciences Inc.
- Codexis Inc.
- Creative Biogene
- CREATIVE ENZYMES
- Enbiotix Inc.
- Illumina Inc.
- Merck Kgaa (Sigma-Aldrich Co. LLC)
- New England Biolabs
- Eurofins Scientific
- Novozymes Pareto Bio, Inc.
- Scarab Genomics, LLC
- Synthego
- Synthetic Genomics Inc.
- Thermo Fisher Scientific, Inc.
